Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Rudick

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2008
Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injuryR J Fox, P Kivisakk, E Fisher, et al.
Journal of Computer Assisted Tomography|September 1, 1992
Volume T1-weighted gradient echo MRI in multiple sclerosis patientsM Shah, J S Ross, C VanDyke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine productionC M Pelfrey, R A Rudick, A C Cotleur, et al.
Archives of Neurology|August 1, 1991
Diagnostic criteria for multiple sclerosis research involving multiply affected familiesD E Goodkin, T H Doolittle, S S Hauser, et al.
Journal of Neuroimmunology|August 1, 1991
Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell lineR M Ransohoff, C Devajyothi, M L Estes, et al.
Neurology|May 22, 1998
In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosisR A Rudick, R M Ransohoff, J C Lee, et al.
Radiology|August 1, 1986
Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MRJ H Simon, S L Holtås, R B Schiffer, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Clinical and Experimental Immunology|August 29, 2002
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS traffickingP Kivisäkk, C Trebst, Z Liu, et al.
Annals of Neurology|January 1, 1995
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2008
Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injuryR J Fox, P Kivisakk, E Fisher, et al.
Journal of Computer Assisted Tomography|September 1, 1992
Volume T1-weighted gradient echo MRI in multiple sclerosis patientsM Shah, J S Ross, C VanDyke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine productionC M Pelfrey, R A Rudick, A C Cotleur, et al.
Archives of Neurology|August 1, 1991
Diagnostic criteria for multiple sclerosis research involving multiply affected familiesD E Goodkin, T H Doolittle, S S Hauser, et al.
Journal of Neuroimmunology|August 1, 1991
Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell lineR M Ransohoff, C Devajyothi, M L Estes, et al.
Neurology|May 22, 1998
In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosisR A Rudick, R M Ransohoff, J C Lee, et al.
Radiology|August 1, 1986
Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MRJ H Simon, S L Holtås, R B Schiffer, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Clinical and Experimental Immunology|August 29, 2002
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS traffickingP Kivisäkk, C Trebst, Z Liu, et al.
Annals of Neurology|January 1, 1995
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.
Pageof 13